New In­di­ca­tions

Pharmacy Daily - - NEWS -

Lu­cen­tis (ranibizumab) is now in­di­cated in adults for the treat­ment of vis­ual im­pair­ment due to choroidal neo­vas­cu­lar­i­sa­tion.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.